Discovery of Irreversible Inhibitors Targeting Histone Methyltransferase, SMYD3

被引:24
|
作者
Huang, Chuhui [1 ]
Liew, Si Si [1 ]
Lin, Grace R. [1 ]
Poulsen, Anders [1 ]
Ang, Melgious J. Y. [1 ]
Chia, Brian C. S. [1 ]
Chew, Sin Yin [1 ]
Kwek, Zekui P. [1 ]
Wee, John L. K. [1 ]
Ong, Esther H. [1 ]
Retna, Priya [1 ]
Baburajendran, Nithya [1 ]
Li, Rong [1 ]
Yu, Weixuan [1 ]
Koh-Stenta, Xiaoying [1 ]
Ngo, Anna [1 ]
Manesh, Sravanthy [1 ]
Fulwood, Justina [1 ]
Ke, Zhiyuan [1 ]
Chung, Hwa Hwa [1 ]
Sepramaniam, Sugunavathi [1 ]
Chew, Xin Hui [1 ]
Dinie, Nurul [1 ]
Lee, May Ann [1 ]
Chew, Yun Shan [1 ]
Low, Choon Bing [1 ]
Pendharkar, Vishal [1 ]
Manoharan, Vithya [1 ]
Vuddagiri, Susmitha [1 ]
Sangthongpitag, Kanda [1 ]
Joy, Joma [1 ]
Matter, Alex [1 ]
Hill, Jeffrey [1 ]
Keller, Thomas H. [1 ]
Foo, Klement [1 ]
机构
[1] Expt Drug Dev Ctr, 10 Biopolis Rd 05-01 Chromos, Singapore 138670, Singapore
来源
ACS MEDICINAL CHEMISTRY LETTERS | 2019年 / 10卷 / 06期
关键词
Epigenetics; Covalent; Irreversible; Methyltransferase; CELL-CULTURE; CANCER; INVASION; GROWTH; MODELS;
D O I
10.1021/acsmedchemlett.9b00170
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
SMYD3 is a histone methyltransferase that regulates gene transcription, and its overexpression is associated with multiple human cancers. A novel class of tetrahydroacridine compounds which inhibit SMYD3 through a covalent mechanism of action is identified. Optimization of these irreversible inhibitors resulted in the discovery of 4-chloroquinolines, a new class of covalent warheads. Tool compound 29 exhibits high potency by inhibiting SMYD3's enzymatic activity and showing antiproliferative activity against HepG2 in 3D cell culture. Our findings suggest that covalent inhibition of SMYD3 may have an impact on SMYD3 biology by affecting expression levels, and this warrants further exploration.
引用
收藏
页码:978 / 984
页数:13
相关论文
共 50 条
  • [1] Discovery of Irreversible Inhibitors Targeting Histone Methyltransferase, SMYD3 (vol 6, pg 978, 2019)
    Huang, Chuhui
    Liew, Si Si
    Lin, Grace R.
    Poulsen, Anders
    Ang, Melgious J. Y.
    Chia, Brian C. S.
    Chew, Sin Yin
    Kwek, Zekui P.
    Wee, John L. K.
    Ong, Esther H.
    Retna, Priya
    Baburajendran, Nithya
    Li, Rong
    Yu, Weixuan
    Koh-Stenta, Xiaoying
    Ngo, Anna
    Manesh, Sravanthy
    Fulwood, Justina
    Ke, Zhiyuan
    Chung, Hwa Hwa
    Sepramaniam, Sugunavathi
    Chew, Xin Hui
    Dinie, Nurul
    Lee, May Ann
    Chew, Yun Shan
    Low, Choon Bing
    Pendharkar, Vishal
    Manoharan, Vithya
    Vuddagiri, Susmitha
    Sangthongpitag, Kanda
    Joy, Joma
    Matter, Alex
    Hill, Jeffrey
    Keller, Thomas H.
    Foo, Klement
    ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (08): : 1240 - 1240
  • [2] Structure-base targeting of SMYD3: An histone methyltransferase involved in colorectal tumorigenesis
    Barbosa, Armenio Jorge M.
    Peserico, Alessia
    Simone, Cristiano
    Del Rio, Alberto
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [3] Structural and Functional Profiling of the Human Histone Methyltransferase SMYD3
    Foreman, Kenneth W.
    Brown, Mark
    Park, Frances
    Emtage, Spencer
    Harriss, June
    Das, Chhaya
    Zhu, Li
    Crew, Andy
    Arnold, Lee
    Shaaban, Salam
    Tucker, Philip
    PLOS ONE, 2011, 6 (07):
  • [4] Histone methyltransferase Smyd3 is a new regulator for vascular senescence
    Yang, Di
    Wei, Gang
    Long, Fen
    Nie, Hongbo
    Tian, Xiaoli
    Qu, Lefeng
    Wang, ShuangXi
    Li, Peng
    Qiu, Yue
    Wang, Yang
    Hong, Wanjin
    Ni, Ting
    Liu, Xinhua
    Zhu, Yi Zhun
    AGING CELL, 2020, 19 (09)
  • [5] Role of the SMYD3 histone methyltransferase in tumorigenesis Local or global effects?
    Medjkane, Souhila
    Cock-Rada, Alicia
    Weitzman, Jonathan B.
    CELL CYCLE, 2012, 11 (10) : 1865 - 1865
  • [6] SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells
    Hamamoto, R
    Furukawa, Y
    Morita, M
    Iimura, Y
    Silva, FP
    Li, MH
    Yagyu, R
    Nakamura, Y
    NATURE CELL BIOLOGY, 2004, 6 (08) : 731 - 740
  • [7] SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells
    Ryuji Hamamoto
    Yoichi Furukawa
    Masashi Morita
    Yuko Iimura
    Fabio Pittella Silva
    Meihua Li
    Ryuichiro Yagyu
    Yusuke Nakamura
    Nature Cell Biology, 2004, 6 : 731 - 740
  • [8] Structural Insights into the Autoinhibition and Posttranslational Activation of Histone Methyltransferase SmyD3
    Sirinupong, Nualpun
    Brunzelle, Joseph
    Doko, Ernada
    Yang, Zhe
    JOURNAL OF MOLECULAR BIOLOGY, 2011, 406 (01) : 149 - 159
  • [9] Discovery of an Allosteric Ligand Binding Site in SMYD3 Lysine Methyltransferase
    Talibov, Vladimir O.
    Fabini, Edoardo
    FitzGerald, Edward A.
    Tedesco, Daniele
    Cederfeldt, Daniela
    Talu, Martin J.
    Rachman, Moira M.
    Mihalic, Filip
    Manoni, Elisabetta
    Naldi, Marina
    Sanese, Paola
    Forte, Giovanna
    Signorile, Martina Lepore
    Barril, Xavier
    Simone, Cristiano
    Bartolini, Manuela
    Dobritzsch, Doreen
    Del Rio, Alberto
    Danielson, U. Helena
    CHEMBIOCHEM, 2021, 22 (09) : 1597 - 1608
  • [10] Histone methyltransferase Smyd3 regulates early embryonic lineage commitment in mice
    Suzuki, Shinnosuke
    Nozawa, Yusuke
    Tsukamoto, Satoshi
    Kaneko, Takehito
    Imai, Hiroshi
    Minami, Naojiro
    REPRODUCTION, 2015, 150 (01) : 21 - 30